Skip to main content
SpringerLink
Log in

Extraokular/Adnexe

  • Chapter
  • First Online:
Entzündliche Augenerkrankungen

  • 2576 Accesses

Zusammenfassung

Eine benigne, idiopathische Entzündung im Bereich der Orbita mit histologisch polymorpher, überwiegend lymphatischer Infiltration, variabler Fibrose und Fehlen einer lokalen oder systemischen Grunderkrankung gilt als idiopathische Orbitaentzündung.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

Literatur zu Abschn. 2.1

  • Bijlsma WR (2011) Progress in etiology, diagnosis, and treatment of idiopathic orbital inflammatory diseases. Utrecht University, In: igitur-archives.library.uu.nl/dissertations/2011-1013-20046/bijlsma.pdf

    Google Scholar 

  • Birch-Hirschfeld A (1906) Zur Diagnostik und Pathologie der Orbitaltumoren. Bericht uber die 32. Versammlung der Deutschen Ophthalmologischen Gesellschaft Heidelberg 1905. J.F.Bergmann, Wiesbaden, S 127–35

    Google Scholar 

  • Blodi FC, Gass JDM (1968) Inflammatory pseudotumor of the orbit. Br J Ophthalmol 52:79–93

    Article  CAS  PubMed  Google Scholar 

  • Brannan PA (2007) A review of sclerosing idiopathic orbital inflammation. Curr Opin Ophthalmol 18:402–4

    Article  PubMed  Google Scholar 

  • Carruth BP, Wladis EJ. Inflammatory modulators and biologic agents in the treatment of idiopathic orbital inflammation. Curr Opin Ophthalmol;23:420–426

    Google Scholar 

  • Char DH, Miller T (1993) Orbital pseudotumor. Fine-needle aspiration biopsy and response to therapy. Ophthalmology 100:1702–10

    Article  CAS  PubMed  Google Scholar 

  • Chaudhry IA, Shamsi FA, Arat YO, Riley FC (2008) Orbital pseudotumor: distinct diagnostic features and management. Middle East Afr J Ophthalmol 15:17–27. doi:10.4103/0974-9233.53370 6179

    Article  PubMed  Google Scholar 

  • Chavis RM, Garner A, Wright JE (1978) Inflammatory orbital pseudotumor. A clinicopathologic study. Arch Ophthalmol 96:1817–22

    Article  CAS  PubMed  Google Scholar 

  • Chundury R, Chundury A, Espinoza G (2012) Nonspecific orbital inflammation. In: http://eyewiki.aao.org/Nonspecific_Orbital_Inflammation_(Idiopathic_orbital_inflammation,_Orbital_inflammatory_syndrome,_Orbital_pseudotumor)

    Google Scholar 

  • Fujii H, Fujisada H, Kondo T, Takahashi T, Okada S (1985) Orbital pseudotumor: histopathological classification and treatment. Ophthalmologica 190:230–42

    Article  CAS  PubMed  Google Scholar 

  • Gordon LK (2006) Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye (Lond) 20:1196–206

    Article  CAS  PubMed  Google Scholar 

  • Günalp I, Gündüz K, Yazar Z (1996) Idiopathic orbital inflammatory disease. Acta Ophthalmol Scand 74:191–3

    Article  PubMed  Google Scholar 

  • Hsuan JD, Selva D, McNab AA, Sullivan TJ, Saeed P, O’Donnell BA (2006) Idiopathic sclerosing orbital inflammation. Arch Ophthalmol 124:1244–50

    Article  PubMed  Google Scholar 

  • Jacobs D, Galetta S (2002) Diagnosis and management of orbital pseudotumor. Curr Opin Ophthalmol 13:347–51

    Article  PubMed  Google Scholar 

  • Kapur R, Sepahdari AR, Mafee MF, Putterman AM, Aakalu V, Wendel LJA, Setabutr P (2009) MR imaging of orbital inflammatory syndrome, orbital cellulitis, and orbital lymphoid lesions: the role of diffusion-weighted imaging. AJNR Am J Neuroradiol 30:64–70

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Karesh JW, Baer JC, Hemady RK (2012) Noninfectious orbital inflammatory disease. In: http://www.oculist.net/downaton502/prof/ebook/duanes/pages/v2/v2c035.html

    Google Scholar 

  • Kubota T. Orbital myositis, idiopathic inflammatory myopathies – recent developements. In: http://www.intechopen.com/books/idiopathic-inflammatory-myopathies-recent-developements/orbital-myositis

    Google Scholar 

  • Lutt JR, Lim LL, Phal PM, Rosenbaum JT (2007) Orbital inflammatory disease. Semin Arthritis Rheum 37:207–22 (Epub 2007 Sep 4)

    Article  PubMed  Google Scholar 

  • Mombaerts I, Schlingemann RO, Goldschmeding R, Koornneef L (1996) Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology 103:521–8

    Article  CAS  PubMed  Google Scholar 

  • Mombaerts I, Goldschmeding R, Schlingemann RO, Koornneef L (1996) What is orbital pseudotumor? Surv Ophthalmol 41:66–78

    Article  CAS  PubMed  Google Scholar 

  • Mombaerts I, Schlingemann RO, Goldschmeding R, Noorduyn LA, Koornneef L (1996) The surgical management of lacrimal gland pseudotumors. Ophthalmology 103:1619–27

    Article  CAS  PubMed  Google Scholar 

  • Mottow LS, Jakobiec FA (1978) Idiopathic inflammatory orbital pseudotumor in childhood. I. Clinical characteristics. Arch Ophthalmol 96:1410–7

    Article  CAS  PubMed  Google Scholar 

  • Plaza JA, Garrity JA, Dogan A, Ananthamurthy A, Witzig TE, Salomao DR (2011) Orbital inflammtion with IgG4-positive plasma cells – Manifestation of IgG4-systemic disease. Arch Ophthalmol 129:421–8

    Article  CAS  PubMed  Google Scholar 

  • Rootman J, Nugent R (1982) The classification and management of acute orbital pseudotumors. Ophthalmology 89:1040–8

    Article  CAS  PubMed  Google Scholar 

  • Sahlmüller M, Schroeter J (2011) Idiopathische entzündliche Orbitopathie. Klin Monatsbl Augenheilkd 228:827–42

    Article  PubMed  Google Scholar 

  • Shields JA, Shields CL, Scartozzi R (2004) Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology 111:997–1008

    Article  PubMed  Google Scholar 

  • Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. New England Journal of Medicine 366:539–51

    Article  CAS  PubMed  Google Scholar 

  • Swamy BN, McCluskey P, Nemet A, Crouch R, Martin P, Benger R, Ghabriel R, Wakefield D (2007) Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol 91:1667–70 (Epub 2007 Jul 9)

    Article  CAS  PubMed  Google Scholar 

  • Yanoff M, Fine BS (1996) Ocular Pathology, 4. Aufl. Mosby-Wolfe, London

    Google Scholar 

  • Yuen SJ, Rubin PA (2003) Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol 121:491–9

    Article  PubMed  Google Scholar 

Literatur zu Abschn. 2.2

  • Bahn RS (2010) Graves’ ophthalmopathy. N Engl J Med 362:726–738

    Article  CAS  PubMed  Google Scholar 

  • Bartalena L, Baldeschi L, Eckstein A, Dickinson AJ et al (2008) Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158:273–285

    Article  CAS  PubMed  Google Scholar 

  • Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA (1996) Clinical features of Graves’ ophthalmopathy in an incidence cohort. Am J Ophthalmol 121:284–290

    CAS  PubMed  Google Scholar 

  • Boergen KP (1993) Schieloperation in Tropfanästhesie bei endokriner Orbitopathie. Z prakt Augenheilkd 14:301–305

    Google Scholar 

  • Ebner R (1993) Botulinum toxin type A in upper lid retraction of Graves’ ophthalmopathy. J Clin Neuroophthalmol 13:258–61

    CAS  PubMed  Google Scholar 

  • Eckstein A, Fischer M, Krüger C, Mohr C, Esser J (2002) Behandlung der schweren endokrinen Orbitopathie mit Optikusdekompression. Z prakt Augenheikd 23:325–330

    Google Scholar 

  • Eckstein A, Schulz S, Esser J (2004) Ist eine kombinierte vertikale und horizontale Augenmuskelchirurgie bei der endokrinen Oritopathie (EO) empfehlenswert? Klin Monatsbl Augenheilkd 221:769–775

    CAS  PubMed  Google Scholar 

  • Eckstein A, Loesch C, Glowacka D, Schott M, Mann K, Esser J, Morgenthaler NG (2009) Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetric Graves ophthalmopathy. Br J Ophthalmol 93:1052–1056

    Article  CAS  PubMed  Google Scholar 

  • Eckstein A, Mann K, Kahaly GJ, Grussendorf M, Reiners C, Feldkamp J, Quadbeck B, Bockisch A, Schott M (2009) Bedeutung der TSH-Rezeptor-Antikörper für die Diagnose des Morbus Basedow sowie die Prognoseabschätzung der Schilddrüsenüberfunktion und der endokrinen Orbitopathie. Stellungnahme der Sektion Schilddrüse der DGE. Med Klin (Munich) 104:343–348

    Article  CAS  Google Scholar 

  • Eckstein A, Weiermüller C, Holdt M, Esser J (2011) Schielformen und Augenmuskeloperationen nach Orbitadekompression. Z prakt Augenheilkd 32:335–344

    Google Scholar 

  • Eckstein A, Schittkowski M, Esser J (2012) Surgical treatment of Graves’ ophthalmopathy. Best practice & research. Clin Endocrinol Metabol 26:339–358

    Google Scholar 

  • Esser J (1994) Endokrine Orbitopathie – Eingriffe an den äußeren Augenmuskeln. Ophthalmologe 91:3–19

    CAS  PubMed  Google Scholar 

  • Esser J, Eckstein A (1999) Ocular muscle and eyelid surgery in thyroid-associated orbitopathy. Exp Clin Endocrinol Diabetes 107(Suppl 5):S214–221

    Article  CAS  PubMed  Google Scholar 

  • Esser J, Schittkowski M, Eckstein A (2011) Endokrine Orbitopathie: M.-rectus-inferior-Sehnenverlängerung bei großen vertikalen Schielwinkeln, die nicht durch eine einfache Muskelrücklagerung korrigiert werden können. Klin Monatsbl Augenheilkd 228:880–886

    Article  CAS  PubMed  Google Scholar 

  • Fenton S, Kemp EG (2002) A review of the outcome of upper lid lowering for eyelid retraction and complications of spacers at a single unit over five years. Orbit 21:289–294

    Article  CAS  PubMed  Google Scholar 

  • Garrity JA, Fatourechi V, Bergstralh EJ, Bartley GB, Beatty CW, DeSanto LW, Gorman CA (1993) Results of transantral orbital decompression in 428 patients with severe Graves’ ophthalmopathy. Am J Ophthalmol 116:533–547

    CAS  PubMed  Google Scholar 

  • Goldberg RA, Perry JD, Hortaleza V, Tong JT (2000) Strabismus after balanced medial plus lateral wall versus lateral wall only orbital decompression for dysthyroid orbitopathy. Ophthal Plast Reconstr Surg 16:271–277

    Article  CAS  PubMed  Google Scholar 

  • Hintschich C, Haritoglou C (2005) Full thickness eyelid transsection (blepharotomy) for upper eyelid lengthening in lid retraction associated with Graves’ disease. Br J Ophthalmol 89:413–416

    Article  CAS  PubMed  Google Scholar 

  • Kalmann R, Mourits MP, van der Pol JP, Koornneef L (1997) Coronal approach for rehabilitative orbital decompression in Graves’ ophthalmopathy. Br J Ophthalmol 81:41–45

    Article  CAS  PubMed  Google Scholar 

  • Lipski A, Eckstein A, Esser J, Loesch C, Mann K, Mohr C, Jurklies B (2010) Course of pattern-reversed visual evoked cortical potentials in 30 eyes after bony orbital decompression in dysthyroid optic neuropathy. Br J Ophthalmol 95:222–226

    Article  PubMed  Google Scholar 

  • Marcocci C, Kahaly GJ, EUGOGO, Krassas GE et al (2011) Placebo-controlled trial of pentoxifylline vs selenium in mild Graves’ orbitopathy (GO). N Engl J Med 364:1920–1931

    Article  CAS  PubMed  Google Scholar 

  • Mourits MP, Sasim IV (1999) A single technique to correct various degrees of upper lid retraction in patients with Graves’ orbitopathy. Br J Ophthalmol 83:81–84

    Article  CAS  PubMed  Google Scholar 

  • Paridaens D, Hans K, van Buitenen S, Mourits MP (1998) The incidence of diplopia following coronal and translid orbital decompression in Graves’ orbitopathy. Eye 12:800–805

    Article  PubMed  Google Scholar 

  • Perros P, Kendall-Taylor P (1998) Natural history of thyroid eye disease. Thyroid 8:423–425

    Article  CAS  PubMed  Google Scholar 

  • Salvi M, Vannucchi G, Campi I, Currò N, Beck-Peccoz P (2008) New immunomodulators in the treatment of Graves’ ophthalmopathy. Ann Endocrinol (Paris) 69:153–156

    Article  CAS  Google Scholar 

  • Wabbels B, Förl M (2007) Botulinumtoxin bei Überfunktion der Tränendrüse, spastischem Entropium und Oberlidretraktion bei endokriner Orbitopathie. Ophthalmologe 104:771–776

    Article  CAS  PubMed  Google Scholar 

  • Wiersinga W, Kahaly G (2007) Graves’s ophthalmopathy. A multidisciplinary approach. Karger, Basel

    Google Scholar 

  • Zang S, Ponto KA, Kahaly GJ (2011) Clinical review: Intravenous glucocorticoids for Graves’ orbitopathy: efficacy and morbidity. J Clin Endocrinol Metabol 96:320–332

    Article  CAS  Google Scholar 

Literatur zu Abschn. 2.3

  • Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG (1993) Visual prognosis in giant cell arteritis. Ophthalmology 100:550–5

    Article  CAS  PubMed  Google Scholar 

  • Bley TA, Uhl M, Carew J et al (2007) Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol 28:1722–7

    Article  CAS  PubMed  Google Scholar 

  • Dasgupta B, Borg FA, Hassan N et al (2010) BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford) 49:1594–7

    Article  Google Scholar 

  • Gonzalez-Gay MA, Lopez-Diaz MJ, Barros S et al (2005) Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine (Baltimore) 84:277–90

    Article  Google Scholar 

  • Hayreh SS, Podhajsky PA, Raman R, Zimmerman B (1997) Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 123:285–96

    CAS  PubMed  Google Scholar 

  • Hunder GG, Bloch DA, Michel BA et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–8

    Article  CAS  PubMed  Google Scholar 

  • Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1–11

    Article  CAS  PubMed  Google Scholar 

  • Kermani TA, Schmidt J, Crowson CS et al (2012) Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 41:866–71

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kermani TA, Warrington KJ, Crowson CS, et al. (2012) Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis 2012

    Google Scholar 

  • Mukhtyar C, Guillevin L, Cid MC et al (2009) EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 68:318–23

    Article  CAS  PubMed  Google Scholar 

  • Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL (2003) Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 48:3522–31

    Article  PubMed  Google Scholar 

  • Ness T, Auw-Hadrich C, Schmidt D (2006) Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment. Ophthalmologe 103:296–301

    Article  CAS  PubMed  Google Scholar 

  • Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93–9

    Article  PubMed  Google Scholar 

  • Salvarani C, Cantini F, Hunder GG (2008) Polymyalgia rheumatica and giant-cell arteritis. Lancet 372:234–45

    Article  PubMed  Google Scholar 

  • Schmidt WA, Gromnica-Ihle E (2005) What is the best approach to diagnosing large-vessel vasculitis? Best Pract Res Clin Rheumatol 19:223–42

    Article  PubMed  Google Scholar 

  • Schmidt WA, Kraft HE, Vorpahl K, Volker L, Gromnica-Ihle EJ (1997) Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337:1336–42

    Article  CAS  PubMed  Google Scholar 

  • Vaith P, Warnatz K (2009) Clinical and serological findings of giant-cell arteritis. Z Rheumatol 68:124–31

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinikum Essen, Zentrum für Augenheilkunde, Universität Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Deutschland

    Anja Eckstein Prof. Dr. med.

  2. Zentrum für Augenheilkunde, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland

    Joachim Esser Prof. Dr. med.

  3. Universitätsaugenklinik Freiburg, Killianstr. 5, 79106, Freiburg, Deutschland

    Thomas Neß PD Dr. med.

  4. Klinik für Ophthalmologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Hegewischstr. 2, 24105, Kiel, Deutschland

    Bernhard Nölle Dr. med.

  5. Univ.-Klinikum Schleswig-Holstein, Campus Kiel, Klinik für Radiologie und Neuroradiologie, Arnold-Heller-Str. 3, Haus 41, 24105, Kiel, Deutschland

    Marcus Both PD. Dr. med.

Authors
  1. Marcus Both PD. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anja Eckstein Prof. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joachim Esser Prof. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thomas Neß PD Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bernhard Nölle Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Berlin Charité Campus Virchow-Klinikum, Berlin, Berlin, Germany

    Uwe Pleyer

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Both, M., Eckstein, A., Esser, J., Neß, T., Nölle, B. (2014). Extraokular/Adnexe. In: Pleyer, U. (eds) Entzündliche Augenerkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38419-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-38419-6_2

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-38418-9

  • Online ISBN: 978-3-642-38419-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation